Press release, 15 March 2023 at 12.45 p.m. EET
Nightingale Health Plc will publish its half-year report for July – December 2022 on Thursday 23 March 2023 at around 9 a.m. EET. The materials will be made available soon after publication at nightingalehealth.com/investors.
Before the publication of the half-year report, Nightingale Health will publish comparative IFRS information for the half-year periods ended on 31 December 2021, and 30 June 2022. The comparative information will be published on Wednesday 22 March 2023.
Nightingale Health will arrange a live webcast for investors and media in English on 23 March 2023 at 2 p.m. EET. You can watch the webcast online at nightingalehealth.videosync.fi/2022-2023-h1-results.
A presentation will be held by CEO Teemu Suna and CFO Tuukka Paavola. A recording of the event will be available later the same day at nightingalehealth.com/investors.
For further information, please contact
Teemu Suna, CEO
About Nightingale Health
Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it’s also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.